LATEST
Israeli Soldiers Describe How Palestinian Families Came to Be Counted as ‘Collateral Damage’Myanmar Genocide Ruling Challenges Israel’s Defence of Its War in GazaSpain’s Marina Escobar Wins the Islantilla Open, the LET Access Series Season FinaleCHASING CanFish F2, the World's First 3-In-1 AI Fishing Scout, Officially Launches on KickstarterPatrick Manser and Evan Luthra Break Ground on BANURU Resort & Residences in ZanzibarIDMERIT Named as Highest-Ranked Identity Verification (IDV) Company on the Inc. 5000 List of America's Fastest-Growing Private CompaniesSophie Bert Leads the Islantilla Open After a Day of Fog, Rain and WindGladia Launches Gladia Connect and Gladia Agency‘I Still Love You, Pal’: Biden’s Secret Farewell Praise for Netanyahu Exposes Contradictions Over Gaza WarSPACECOOL Launches “SPACECOOL Heat Shield VT,” Featuring Zero-Energy Radiative Cooling Technology, on Kickstarter “Carry Your Own Tree Shade” — An Innovative Japanese Product Combining Advanced Cooling Technology with Portable Sun ProtectionIsraeli Soldiers Describe How Palestinian Families Came to Be Counted as ‘Collateral Damage’Myanmar Genocide Ruling Challenges Israel’s Defence of Its War in GazaSpain’s Marina Escobar Wins the Islantilla Open, the LET Access Series Season FinaleCHASING CanFish F2, the World's First 3-In-1 AI Fishing Scout, Officially Launches on KickstarterPatrick Manser and Evan Luthra Break Ground on BANURU Resort & Residences in ZanzibarIDMERIT Named as Highest-Ranked Identity Verification (IDV) Company on the Inc. 5000 List of America's Fastest-Growing Private CompaniesSophie Bert Leads the Islantilla Open After a Day of Fog, Rain and WindGladia Launches Gladia Connect and Gladia Agency‘I Still Love You, Pal’: Biden’s Secret Farewell Praise for Netanyahu Exposes Contradictions Over Gaza WarSPACECOOL Launches “SPACECOOL Heat Shield VT,” Featuring Zero-Energy Radiative Cooling Technology, on Kickstarter “Carry Your Own Tree Shade” — An Innovative Japanese Product Combining Advanced Cooling Technology with Portable Sun Protection
Business

ProMIS Announces Completion of Continuance

ProMIS Neurosciences Inc. (TSX: PMN) (NASDAQ: PMN) (“ProMIS” or the “Corporation”) is pleased to announce that it has completed its continuance (the “Continuance”) from the Canada Business Corporations Act into the Province of Ontario under the Business Corporations Act (Ontario) as of July 13, 2023. The Continuance was approved by the Corporation’s shareholders with a 97.7% majority via a special resolution at the Corporation’s Annual Meeting of Shareholders held on June 29, 2023. The shift will facilitate internal management functions, and is not envisioned to impact operations. The Company continues to operate with its headquarters in Toronto as well as its research laboratories, under the direction of Chief Scientific Officer Dr. Neil Cashman, in British Columbia and its US office in Cambridge, MA.
  No action will be required by existing shareholders with respect to the Continuance.  

ProMIS Neurosciences Inc. is a development stage biotechnology corporation focused on discovering and developing antibody therapeutics selectively targeting toxic oligomers implicated in the development and progression of neurodegenerative diseases, in particular Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and Multiple system atrophy (MSA). The Corporation’s proprietary target discovery engine is based on the use of two complementary techniques. The Corporation applies its thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this unique approach, the Corporation is developing novel antibody therapeutics for AD, ALS and MSA.  ProMIS is headquartered in Toronto, Ontario, Canada with offices in Cambridge, Massachusetts, U.S.A. ProMIS is listed on the TSX under symbol PMN, and on the NASDAQ under the symbol PMN.

Related articles

Top